semaglutide for obesity houma New Wegovy dosage was approved last month & is set to launch in April! #obesitymedicine #glp1 #pasofinsta #physicianassociate The effects of semaglutide on

doi: Ghusn W, De la Rosa A, Sacoto D, et al

Watch for: Sudden, intense pain in the upper right abdomen Pain between the shoulder blades Nausea and vomiting not related to meals Yellowing of the skin or eyes (jaundice) Thyroid concerns Semaglutide carries a boxed warning about thyroid C-cell tumors based on animal studies

GLP-1 signaling suppresses the expression of various pro-atherosclerotic factors in vascular endothelial cells induced by hyperglycemia and inflammatory cytokines (e.g

kidney problems (kidney failure)

GLP-1RA-induced delays in gastrointestinal motility and pharmacokinetic interactions with oral medications

But the complete formulation - the active ingredient plus all of the inactive ingredients (excipients) that make up the final product - differs between compounded and brand-name versions